Your account is not claimed yet. You can sign up with ORCID to claim your account.

Matthias E Liechti

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 35

Top Venues

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Journal of psychopharmacology (Oxford, England)

Clinical pharmacology and therapeutics

British journal of clinical pharmacology

University Hospital Basel

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University Hospital Basel

Switzerland

Professor :: Clinical Pharmacology and Toxicology

Publications

Roberta Noseda, Matteo Franchi, Alberto Pagnamenta, Laura Müller, Alison M Dines, Isabelle Giraudon, Fridtjof Heyerdahl, Florian Eyer, Knut Erik Hovda, Matthias E Liechti, Òscar Miró, Odd Martin Vallersnes, Christopher Yates, Paul I Dargan, David M Wood, Alessandro Ceschi, null On Behalf Of The Euro-DEN Plus Research Group
Determinants of Admission to Critical Care Following Acute Recreational Drug Toxicity: A Euro-DEN Plus Study. Journal of clinical medicine 12 (18) (2023)
Isabelle Straumann, Laura Ley, Friederike Holze, Anna M Becker, Aaron Klaiber, Kathrin Wey, Urs Duthaler, Nimmy Varghese, Anne Eckert, Matthias E Liechti
Acute effects of MDMA and LSD co-administration in a double-blind placebo-controlled study in healthy participants. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology (2023)
Friederike Holze, Livio Erne, Urs Duthaler, Matthias E Liechti
Pharmacokinetics, pharmacodynamics and urinary recovery of oral lysergic acid diethylamide (LSD) administration in healthy participants. British journal of clinical pharmacology (2023)
Laura Ley, Friederike Holze, Denis Arikci, Anna M Becker, Isabelle Straumann, Aaron Klaiber, Fabio Coviello, Sophie Dierbach, Jan Thomann, Urs Duthaler, Dino Luethi, Nimmy Varghese, Anne Eckert, Matthias E Liechti
Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology (2023)
Peter Bedford, Daniel J Hauke, Zheng Wang, Volker Roth, Monika Nagy-Huber, Friederike Holze, Laura Ley, Patrick Vizeli, Matthias E Liechti, Stefan Borgwardt, Felix Müller, Andreea O Diaconescu
The effect of lysergic acid diethylamide (LSD) on whole-brain functional and effective connectivity. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology (2023)
Verena Angerer, Yasmin Schmid, Florian Franz, Heike Gnann, Jan Manuel Speer, Anke Gnann, Stephan Helmecke, Armin Buchwald, Simon D Brandt, Torsten Passie, Matthias E Liechti, Volker Auwärter
Acute psychotropic, autonomic, and endocrine effects of 5,6-methylenedioxy-2-aminoindane (MDAI) compared with 3,4-methylenedioxymethamphetamine (MDMA) in human volunteers: A self-administration study. Drug testing and analysis (2023)
Kurt Stocker, Matthias Hartmann, Laura Ley, Anna M Becker, Friederike Holze, Matthias E Liechti
The revival of the psychedelic experience scale: Revealing its extended-mystical, visual, and distressing experiential spectrum with LSD and psilocybin studies. Journal of psychopharmacology (Oxford, England) (2023)
Severin B Vogt, Laura Ley, Livio Erne, Isabelle Straumann, Anna M Becker, Aaron Klaiber, Friederike Holze, Anja Vandersmissen, Lorenz Mueller, Urs Duthaler, Deborah Rudin, Dino Luethi, Nimmy Varghese, Anne Eckert, Matthias E Liechti
Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants. Translational psychiatry 13 (1) (2023)
Friederike Holze, Anna M Becker, Karolina E Kolaczynska, Urs Duthaler, Matthias E Liechti
Pharmacokinetics and Pharmacodynamics of Oral Psilocybin Administration in Healthy Participants. Clinical pharmacology and therapeutics 113 (4) (2022)
Benjamin Crulli, Alison M Dines, Georgina Blanco, Isabelle Giraudon, Florian Eyer, Matthias E Liechti, Òscar Miró, Knut Erik Hovda, Fridtjof Heyerdahl, Christopher Yates, Odd Martin Vallersnes, David M Wood, Paul I Dargan, null null
Novel psychoactive substances-related presentations to the emergency departments of the European drug emergencies network plus (Euro-DEN plus) over the six-year period 2014-2019. Clinical toxicology (Philadelphia, Pa.) (2022)
Friederike Holze, Anna M Becker, Karolina E Kolaczynska, Urs Duthaler, Matthias E Liechti
Pharmacokinetics and Pharmacodynamics of Oral Psilocybin Administration in Healthy Participants. Clinical pharmacology and therapeutics 113 (4) (2022)
Friederike Holze, Laura Ley, Felix Müller, Anna M Becker, Isabelle Straumann, Patrick Vizeli, Sebastian Silva Kuehne, Marc A Roder, Urs Duthaler, Karolina E Kolaczynska, Nimmy Varghese, Anne Eckert, Matthias E Liechti
Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 47 (6) (2022)
Friederike Holze, Anna M Becker, Karolina E Kolaczynska, Urs Duthaler, Matthias E Liechti
Pharmacokinetics and Pharmacodynamics of Oral Psilocybin Administration in Healthy Participants. Clinical pharmacology and therapeutics (2022)
Friederike Holze, Anna M Becker, Karolina E Kolaczynska, Urs Duthaler, Matthias E Liechti
Pharmacokinetics and pharmacodynamics of oral psilocybin administration in healthy participants. Clinical pharmacology and therapeutics (2022)
Anna M Becker, Aaron Klaiber, Friederike Holze, Ioanna Istampoulouoglou, Urs Duthaler, Nimmy Varghese, Anne Eckert, Matthias E Liechti
Ketanserin reverses the acute response to LSD in a randomized, double-blind, placebo-controlled, crossover study in healthy subjects. The international journal of neuropsychopharmacology (2022)
Karolina E Kolaczynska, Jan Thomann, Marius C Hoener, Matthias E Liechti
The Pharmacological Profile of Second Generation Pyrovalerone Cathinones and Related Cathinone Derivative. International journal of molecular sciences 22 (15) (2021)
Anna M Becker, Friederike Holze, Tanja Grandinetti, Aaron Klaiber, Vanja E Toedtli, Karolina E Kolaczynska, Urs Duthaler, Nimmy Varghese, Anne Eckert, Edna Grünblatt, Matthias E Liechti
Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects. Clinical pharmacology and therapeutics (2021)
Erich Studerus, Patrick Vizeli, Samuel Harder, Laura Ley, Matthias E Liechti
Prediction of MDMA response in healthy humans: a pooled analysis of placebo-controlled studies. Journal of psychopharmacology (Oxford, England) 35 (5) (2021)
Johannes G Ramaekers, Nadia R P W Hutten, Natasha L Mason, Patrick Dolder, Eef L Theunissen, Friederike Holze, Matthias E Liechti, Amanda Feilding, Kim Paula Colette Kuypers
A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers. Journal of psychopharmacology (Oxford, England) 35 (4) (2020)
Yasmin Schmid, Peter Gasser, Peter Oehen, Matthias E Liechti
Acute subjective effects in LSD- and MDMA-assisted psychotherapy. Journal of psychopharmacology (Oxford, England) 35 (4) (2020)
Felix Müller, Friederike Holze, Patrick Dolder, Laura Ley, Patrick Vizeli, Alain Soltermann, Matthias E Liechti, Stefan Borgwardt
MDMA-induced changes in within-network connectivity contradict the specificity of these alterations for the effects of serotonergic hallucinogens. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 46 (3) (2020)
Andrea Eva Steuer, Daria Kaelin, Martina I Boxler, Lisa Eisenbeiss, Friederike Holze, Patrick Vizeli, Joanna Czerwinska, Paul I Dargan, Vincenzo Abbate, Matthias E Liechti, Thomas Kraemer
Comparative Untargeted Metabolomics Analysis of the Psychostimulants 3,4-Methylenedioxy-Methamphetamine (MDMA), Amphetamine, and the Novel Psychoactive Substance Mephedrone after Controlled Drug Administration to Humans. Metabolites 10 (8) (2020)
Friederike Holze, Patrick Vizeli, Laura Ley, Felix Müller, Patrick Dolder, Melanie Stocker, Urs Duthaler, Nimmy Varghese, Anne Eckert, Stefan Borgwardt, Matthias E Liechti
Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 46 (3) (2020)
Xun Zhou, Jamal Bouitbir, Matthias E Liechti, Stephan Krähenbühl, Riccardo Vincenzo Mancuso
Hyperthermia Increases Neurotoxicity Associated with Novel Methcathinones. Cells 9 (4) (2020)
Xun Zhou, Jamal Bouitbir, Matthias E Liechti, Stephan Krähenbühl, Riccardo Vincenzo Mancuso
Para-Halogenation of Amphetamine and Methcathinone Increases the Mitochondrial Toxicity in Undifferentiated and Differentiated SH-SY5Y Cells. International journal of molecular sciences 21 (8) (2020)
Dino Luethi, Matthias E Liechti
Designer drugs: mechanism of action and adverse effects. Archives of toxicology 94 (4) (2020)
Friederike Holze, Urs Duthaler, Patrick Vizeli, Felix Müller, Stefan Borgwardt, Matthias E Liechti
Pharmacokinetics and subjective effects of a novel oral LSD formulation in healthy subjects. British journal of clinical pharmacology 85 (7) (2019)
Patrick Vizeli, Henriette E Meyer Zu Schwabedissen, Matthias E Liechti
Role of Serotonin Transporter and Receptor Gene Variations in the Acute Effects of MDMA in Healthy Subjects. ACS chemical neuroscience 10 (7) (2019)
Katharina Elisabeth Grafinger, Matthias E Liechti, Evangelia Liakoni
Clinical value of analytical testing in patients presenting with new psychoactive substances intoxication. British journal of clinical pharmacology 86 (3) (2019)
Friederike Holze, Patrick Vizeli, Felix Müller, Laura Ley, Raoul Duerig, Nimmy Varghese, Anne Eckert, Stefan Borgwardt, Matthias E Liechti
Distinct acute effects of LSD, MDMA, and D-amphetamine in healthy subjects. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 45 (3) (2019)
Dino Luethi, Karolina E Kolaczynska, Melanie Walter, Masaki Suzuki, Kenner C Rice, Bruce E Blough, Marius C Hoener, Michael H Baumann, Matthias E Liechti
Metabolites of the ring-substituted stimulants MDMA, methylone and MDPV differentially affect human monoaminergic systems. Journal of psychopharmacology (Oxford, England) 33 (7) (2019)
Xun Zhou, Dino Luethi, Gerda M Sanvee, Jamal Bouitbir, Matthias E Liechti, Stephan Krähenbühl
Molecular Toxicological Mechanisms of Synthetic Cathinones on C2C12 Myoblasts. International journal of molecular sciences 20 (7) (2019)
Patrick Vizeli, Matthias E Liechti
Oxytocin receptor gene variations and socio-emotional effects of MDMA: A pooled analysis of controlled studies in healthy subjects. PloS one 13 (6) (2018)
Anna Rickli, Evangelia Liakoni, Marius C Hoener, Matthias E Liechti
Opioid-induced inhibition of the human 5-HT and noradrenaline transporters in vitro: link to clinical reports of serotonin syndrome. British journal of pharmacology 175 (3) (2018)
Patrick Vizeli, Henriette E Meyer Zu Schwabedissen, Matthias E Liechti
No major role of norepinephrine transporter gene variations in the cardiostimulant effects of MDMA. European journal of clinical pharmacology 74 (3) (2017)

Matthias E Liechti.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Matthias E Liechti